Skip to content

Clinical trials summarized as Visual Abstracts

Submit Article
About
Private Policy
Visualmed App for iphone
Visualmed App for Android
List of Clinical Trials

TECOS Trial: Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes

by adminPosted onMay 2, 2020July 24, 2020

Posted in Cardiovascular Disease, EndocrinologyTagged CV outcomes, diabetes, sitagliptin, type 2 diabetes

Post navigation

Prev TARGET Trial: Energy-Dense versus Routine Enteral Nutrition in the Critically Ill

Next THEMIS PCI Trial: Ticagrelor in patients with diabetes and CAD with a history of PCI

Search for:

Subscribe via Email

Name*

Email*

Select list(s)*

Cardiovascular Disease

Infectious Disease

Dermatology

Emergency Medicine

Endocrinology

Gastroenterology

Geriatrics

Hematology/Oncology

Nephrology

Neurology

Surgery

Pulmonary/Critical Care

Rheumatology

Please accept terms & condition

Amphibious Theme by TemplatePocket ⋅ Powered by WordPress